Regeneron Pharmaceuticals
$828.42
24H
Market Cap
Volume
Supply
Price Chart
About Regeneron Pharmaceuticals - REGN
Regeneron Pharmaceuticals, Inc. is an American biotechnology company that focuses on researching and developing medications for the treatment of serious medical conditions, well-known for their innovative drug therapies in areas such as oncology, inflammatory, and eye diseases.
What are Regeneron Pharmaceuticals's core values and mission statement?
Regeneron Pharmaceuticals, Inc. is dedicated to using the power of science to bring new medicines to patients in need, and their mission centers on discovering, inventing, developing, manufacturing, and commercializing therapies that offer significant benefits to patients with serious conditions. Core values include a commitment to science, a belief in the power of creativity and innovation, and a dedication to transforming outcomes for patients with serious diseases.
Who founded Regeneron Pharmaceuticals and when?
Regeneron Pharmaceuticals, Inc. was founded by Leonard S. Schleifer and George D. Yancopoulos in 1988.
Who leads Regeneron Pharmaceuticals?
As of the last update, Leonard S. Schleifer co-founded Regeneron Pharmaceuticals, Inc. and serves as President and CEO, with George D. Yancopoulos as the President and Chief Scientific Officer.
Where is Regeneron Pharmaceuticals located, and what is its base country?
Regeneron Pharmaceuticals, Inc. is located in Tarrytown, New York, and its base country is the United States.
On which exchanges is Regeneron Pharmaceuticals traded?
Regeneron Pharmaceuticals, Inc. is traded on the NASDAQ stock exchange under the ticker symbol REGN.
Historical data
Regeneron Pharmaceuticals (REGN) Price Live Data
The live price of Regeneron Pharmaceuticals (REGN) is $828.42, with a trading volume of 556,160 in the last 24 hours. Wrapstocks updates the REGN price in real-time. Regeneron Pharmaceuticals is up 0.48% in the last 24 hours. The company has a live market cap of $91,035,074,560.00 and a supply of 109,890,001 REGN stocks.
Regeneron Pharmaceuticals (REGN) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 4 hours and 7 minutes.
